Éric Dansin

机构：Centre Oscar Lambret

发表论文 332 篇 · 总被引 12460 次 · h-index 31

代表论文

• French guidelines from the GTE, AFCE and ENDOCAN-RENATEN (Groupe d’étude des Tumeurs Endocrines/Association Francophone de Chirurgie Endocrinienne/Reseau national de prise en charge des tumeurs endocrines) for the screening, diagnosis and management of Multiple Endocrine Neoplasia Type 1 (2023 · Annales d Endocrinologie · 被引 33)
• Treatment of advanced BP-NETS with lanreotide autogel/depot vs placebo: the phase III SPINET study (2024 · Endocrine Related Cancer · 被引 26)
• Clinical characteristic and survival outcomes of patients with advanced NSCLC according to KRAS mutational status in the French real-life ESME cohort (2024 · ESMO Open · 被引 14)
• LBA83 PECATI: A phase II trial to evaluate the efficacy and safety of lenvatinib in combination with pembrolizumab in pretreated advanced B3-thymoma and thymic carcinoma (2024 · Annals of Oncology · 被引 11)
• Lenvatinib plus pembrolizumab in pretreated metastatic B3 thymoma and thymic carcinoma (PECATI): a single-arm, phase 2 trial (2025 · The Lancet Oncology · 被引 10)
• Efficacy of first-line treatments for advanced pulmonary sarcomatoid carcinomas: a real-world analysis (2025 · ESMO Open · 被引 9)